Seeking Alpha

Buckingham says Watson Pharmaceuticals (WPI -1.3%) remains a Top Pick , given its attractive...

Buckingham says Watson Pharmaceuticals (WPI -1.3%) remains a Top Pick , given its attractive growth profile, Actavis acquisition benefits and continued settlement discussions with Endo (ENDP -0.8%). The firm reiterates its Buy rating with a $100 price target.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs